<DOC>
	<DOCNO>NCT00215137</DOCNO>
	<brief_summary>This study determine safety effectiveness escitalopram ( Lexapro ) treat obsessive-compulsive disorder ( OCD ) symptom .</brief_summary>
	<brief_title>Pilot Study Evaluate Escitalopram Obsessive-compulsive Disorder</brief_title>
	<detailed_description>OCD chronic disable disorder Selective Serotonin Reuptake Inhibitor ( SSRI ) drug effective . The purpose study evaluate effect SSRI , escitalopram , OCD patient . This study last 16 week comprise 2 phase . Phase 1 open label participant receive daily escitalopram 8 week . Those respond treatment end 8 week randomly assign either continue discontinue treatment additional 8 week . Those respond treatment end Phase 1 discontinue study offer three free visit study clinician refer elsewhere treatment , base preference . Study visit make baseline , Weeks 1 , 2 , 4 , 8 Phase 1 Weeks 12 16 Phase 2 .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Diagnosis OCD A minimum score 16 Yale Brown ObsessiveCompulsive Scale ( YBOCS ) screen baseline visit Lifetime history psychosis cognitive dysfunction due general medical condition substance use A primary diagnosis another Axis I psychiatric disorder Alcohol substance abuse dependence within last 6 month Unstable medical condition Clinically significant laboratory abnormality Failure previous 10week trial citalopram least 40 mg/day escitalopram 20 mg/day Active suicidality History violent behavior past year current risk serious violence A history sensitivity citalopram escitalopram Use investigational drug within 30 day baseline psychotropic drug herbs within 14 day baseline ( 28 day fluoxetine ) Need concurrent psychotherapeutic intervention Pregnant lactating female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>OCD</keyword>
	<keyword>SSRI</keyword>
	<keyword>escitalopram</keyword>
	<keyword>relapse</keyword>
</DOC>